首页> Drug delivery and translational research> Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation

Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation

导出原文传递

翻译打印收藏纠错

第一作者： Shruti S.,Sawant

作者： Shruti S.,Sawant ^[1] ; Suyash M.,Patil ; Snehal K.,Shukla ; Nishant S.,Kulkarni ; Vivek,Gupta ; Nitesh K.,Kunda

作者单位： Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences,St. John’s University ^[1]

关键词 Osimertinib Lung cancer Pulmonary delivery Liposomes Nebulization

发布时间 2023-01-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Drug delivery and translational research

2022年12卷10期

2474-2487页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Drug delivery and translational research

2022年12卷10期

2474-2487页

检索历史清除

Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation

Drug delivery and translational research

相似文献

同项目论文

Drug delivery and translational research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation

Drug delivery and translational research

相似文献

同项目论文

Drug delivery and translational research

相关期刊

检索历史清除